Haystack Oncology
Who we are
Powered by pioneers in liquid biopsy
Haystack Oncology is based on over 20 years of liquid biopsy technology and clinical development led by the scientists specialized in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease therapy monitoring. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated billions of dollars in enterprise value.
Scientific Founders

Bert Vogelstein, M.D.
Professor of Oncology

Kenneth Kinzler, Ph.D.
Director, Ludwig Center at Johns Hopkins University Professor of Oncology

Nick Papadopoulos, Ph.D.
Professor of Oncology
Leadership
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Learn more
Board of Directors
Chairman
Isaac
Ro
Founder & Director
Dr. Nicholas
Papadopoulos
Director
Dan
Edelstein
Director
George C.
Petrocheilos
Director
R. Jacob
Vogelstein
Clinical Scientific Advisors
Haystack Oncology’s clinical advisory board brings a diversity of thought leadership among oncology experts, and is foundational to our mission of providing better MRD testing for better patient outcomes.
Chetan Bettegowda, MD, Ph.D.
Professor of Neurosurgery and Oncology | Vice Chair, Department of Neurosurgery
Johns Hopkins School of Medicine
Al Benson, MD
Professor of Medicine, Hematology and Oncology | NCCN Board of Directors | Chair, NCCN Hepatobiliary, Colon & Rectal Guidelines Panel | Member, NCCN Pancreatic Cancer and Neuroendocrine Panels
Northwestern University
Nilofer Saba Azad, MD
Professor of Oncology | Co-Director, Developmental Therapeutics Program/Phase I Program | NCCN Guidelines Panel, Colon Cancer
Nishant Agrawal, MD
Professor of Surgery | Chief of Otolaryngology-Head and Neck Surgery | Co-Director of Head and Neck Surgical Oncology
University of Chicago
Afsaneh Barzi, MD, Ph.D.
Associate Professor, Department of Medical Oncology & Therapeutics Research | Vice President, Quality and Value
City of Hope/AcessHope
Peter Gibbs, MD
Professor of Medicine
Walter and Eliza Hall Institute
Jeanne Tie, MD
Associate Professor of Medicine
Walter and Eliza Hall Institute
Patrick Boland, MD
Assistant Professor, Medical Oncology
Rutgers Cancer Institute
Josh Cohen, MD, Ph.D
Technology Innovation
Johns Hopkins School of Medicine
News & Events
The Latest
Find out what's happening at Haystack Oncology and stay up-to-date with industry news.
Precision Medicine World Conference 2023 Silicon Valley
Haystack’s co-founder and Chief Innovation Officer, Josh Cohen, will be participating in a panel discussion at the upcoming Precision Medicine World Confe ...
ASCO GI Annual Meeting
Haystack is looking forward to attending the ASCO Gastrointestinal Cancers Annual Symposium taking place January 19-21 in San Francisco, CA. ASCO GI will ...